Physician profile
Madelyn Holzman
NPI 1184624769
$3,284.56
in general payments reported to CMS, 2019-2025
16 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $434 · 2021: $411 · 2022: $649 · 2023: $673 · 2024: $289 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.67 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,795.88 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia |
| Astellas Pharma US INC | $417.52 | 2019-2025 | Padcev, Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $269.99 | 2019-2023 | Erleada |
| Procept Biorobotics Corporation | $185.09 | 2022-2024 | Aquabeam System |
| Merck Sharp & Dohme LLC | $132.57 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Sumitomo Pharma America, INC. | $98.98 | 2025 | |
| Boston Scientific Corporation | $67.94 | 2019-2021 | |
| Pfizer INC. | $62.23 | 2019 | |
| Teleflex LLC | $56.56 | 2022-2025 | Urolift |
| Allergan, INC. | $46.77 | 2019-2021 | |
| Myovant Sciences INC. | $45.06 | 2022 | |
| Ferring Pharmaceuticals INC. | $25.19 | 2019 | |
| Abbvie INC. | $24.87 | 2024 | |
| Accord Healthcare, INC. | $23.97 | 2024 | |
| Laborie Medical Technologies Corp. | $19.07 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madelyn Holzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.